Bioprocessing of Viral Vaccines

About

Amine Kamen is a professor of bioengineering at McGill University and CanadaResearch Chair in bioprocessing of viral vaccines. He is a researcher emeritus of theNational Research Council of Canada (NRC) where he was employed until early2014 as head of the Process Development section of the Human Health TherapeuticsPortfolio. At NRC he established one of North Americas largest and most advancedgovernmental centers for animal cell culture addressing process development andscale-up of biologics. Also he developed with his team and licensed to industrymultiple technology platforms for efficient manufacturing of recombinant proteinsand viral vectors and vaccines and led technology transfer to manufacturing sites forclinical evaluation and commercialization. His current research activities focus onuncovering mechanisms associated with cell production of viral vectors and viralvaccines cell and metabolic engineering process control and monitoring and processanalytical technologies of high-yield productions of viral vectors for gene deliveryand vaccination. He has published over 170 papers in refereed international journalsand acts as a consultant for several national and international private and publicorganizations.Laura Cervera is a Chemical Engineer from Universitat Autònoma de Barcelona(Barcelona Spain). After graduating she did her PhD in Biotechnology on the topicStrategies for improving production levels of HIV-1 VLPs by transient transfectionof HEK 293 suspension cultures. Then she moved to McGillUniversity (MontrealCanada) to pursue her research on VLP production this time using Insect cells as aplatform. She came back to Barcelona to join a project on AAV production for genetherapy applications using HEK 293 cells.